Qingyu Yangjing Formula Ameliorates Cyclophosphamide-Induced Oligoasthenospermia by Regulating the Hypothalamic-Pituitary-Gonadal Axis and Inhibiting Testicular Oxidative Stress and Apoptosis in Rats

TCM formula QYYJF improved sperm motility and HPG axis hormones in chemotherapy-damaged rats, via 25 identified serum compounds

Journal: Journal of Ethnopharmacology | Published: 2025-10-31 | Type: Journal Article | PMID: 41177240 Authors: Li Xiran et al. — Jiangsu Province Hospital of Chinese Medicine / Nanjing University of Chinese Medicine Funding/COI: Funding not disclosed; authors declare no competing interests

Summary

A Chinese medicine research group tested Qingyu Yangjing Formula (QYYJF), a TCM herbal preparation, on rats whose fertility was chemically destroyed with cyclophosphamide. The formula improved sperm density, motility, and hormonal markers compared to untreated damaged rats. This is a rat study with no human data.

Claims

• Cyclophosphamide (40 mg/kg IP, 5 days) reduced testicular weight, sperm density, and sperm motility in male Sprague-Dawley rats
• QYYJF at three doses (5.77, 11.55, and 17.32 g/kg/day, 14 days) partially reversed these effects
• 515 prototype compounds were detected in rat serum after QYYJF dosing; 25 were structurally characterized (primarily flavonoids, triterpenoid saponins, phenylpropanoids, and lactones)
• Treatment reduced oxidative stress markers, inflammatory cytokines (via ELISA), and pro-apoptotic protein expression (Bax, cleaved Caspase-3, cleaved Caspase-9), while increasing Bcl-2
• HPG axis hormones were "restored" — no specific values given in abstract

Study Quality

Forty rats split across five groups (untreated control, CP-only, and three QYYJF doses) means roughly 8 animals per group — barely powered to detect anything. The abstract reports no actual numbers: no mean sperm concentrations, no hormone values, no p-values, no effect sizes. "Ameliorated," "restored," and "reduced" appear throughout without quantification. The chemotherapy-induced infertility model is real but has limited translational value: cyclophosphamide causes broad systemic toxicity, not the idiopathic or genetic infertility that represents most clinical OAS cases.

UPLC-Q-TOF-MS/MS analysis of 515 compounds is technically sophisticated, but identifying 515 chemicals in rat blood and then attributing benefit to 25 of them without mechanistic isolation is not mechanism elucidation — it's a list. No single compound was tested independently.

Red Flags

• No human data; extrapolating from CP-damaged rats to clinical infertility is a large leap
• Abstract contains zero quantitative results — no numbers, no statistics
• N=8 per group is underpowered for reliable conclusions
• 515 serum compounds make true mechanism attribution impossible
• Funding source not disclosed; authors are affiliated with a Chinese medicine hospital with institutional stake in TCM validation
• Cyclophosphamide model does not represent typical male infertility etiology
• No pharmacokinetic or toxicity data on QYYJF itself reported

Strengths

• Multi-dose design allows crude dose-response assessment
• Broad biomarker panel (hormones, oxidative stress, apoptosis, histology) gives mechanistic breadth
• Mass spectrometry characterization of absorbed compounds is more rigorous than most TCM papers, which skip this entirely
• No declared commercial COI

Verdict

This is a small, under-reported animal study that demonstrates QYYJF does something to cyclophosphamide-damaged rat testes — but won't tell you what, how much, or whether it matters. The absence of any quantitative data in the abstract is a serious credibility problem for a results-oriented paper. The 515-compound serum profile is analytically impressive and scientifically meaningless for mechanism claims. Until QYYJF is tested in humans with pre-specified endpoints and reported with actual numbers, this is a hypothesis, not evidence.